Across TCGA pan-cancer cohorts, CCT4P2 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of CCT4P2’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where CCT4P2 RNA is repressed in tumor relative to normal tissue. In most cancer types CCT4P2 is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

LUSC, STAD, and THCA are the cancer types where CCT4P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CCT4P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	−0.028	.025	2	view →
STAD	All	II,III,IV	+0.222	.031	1	view →
THCA	Male	IV	−0.063	.001	1	view →
KICH	All	All	−0.010	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: CCT4P2 RNA expression & survival · all CCT4P2 data types